CCIA
AMAG

Campbell & Co Investment Adviser’s AMAG Pharmaceuticals AMAG Stock Holding History

Campbell & Co Investment Adviser’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-32,421
Closed -$324K – 830
2019
Q2 		$324K Buy
+32,421
New +$350K 0.15% 284
2015
Q4 		– Sell
-13,352
Closed -$530K – 289
2015
Q3 		$530K Buy
+13,352
New +$829K 0.35% 93

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Campbell & Co Investment Adviser's AMAG Position: Q3 2019 in Review

Campbell & Co Investment Adviser sold out of AMAG Pharmaceuticals (AMAG) in Q3 2019, closing a stake of 32,421 shares — an estimated $324K sold.

Campbell & Co Investment Adviser first reported a position in AMAG in Q3 2015 and held it in 2 quarters. The position peaked at $530K in Q3 2015. 156 funds tracked by Wall St. Rank hold AMAG as of Q3 2019.

  • Campbell & Co Investment Adviser reported no remaining AMAG Pharmaceuticals position as of Q3 2019 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 32,421 AMAG Pharmaceuticals shares in Q3 2019, an estimated $324K.
  • Campbell & Co Investment Adviser first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 2 quarters.
  • Campbell & Co Investment Adviser's AMAG Pharmaceuticals position peaked at $530K in Q3 2015.
  • 156 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2019.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2019, filed 16 Oct 2019.